229 related articles for article (PubMed ID: 35582725)
1. The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic opportunities.
Meyer LK; Hermiston ML
Cancer Drug Resist; 2019; 2(2):313-325. PubMed ID: 35582725
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia.
Xu H; Yu H; Jin R; Wu X; Chen H
Cells; 2021 Nov; 10(12):. PubMed ID: 34943855
[TBL] [Abstract][Full Text] [Related]
3. The landscape of alterations affecting epigenetic regulators in T-cell acute lymphoblastic leukemia: Roles in leukemogenesis and therapeutic opportunities.
Walia Y; de Bock CE; Huang Y
Int J Cancer; 2024 May; 154(9):1522-1536. PubMed ID: 38155420
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic modifications in pediatric acute lymphoblastic leukemia.
Burke MJ; Bhatla T
Front Pediatr; 2014; 2():42. PubMed ID: 24860797
[TBL] [Abstract][Full Text] [Related]
5. [Genetic and epigenetic landscape of pediatric T-cell acute lymphoblastic leukemia].
Kimura S
Rinsho Ketsueki; 2019; 60(5):459-467. PubMed ID: 31168014
[TBL] [Abstract][Full Text] [Related]
6. The epigenetic landscape of T-cell acute lymphoblastic leukemia.
Van der Meulen J; Van Roy N; Van Vlierberghe P; Speleman F
Int J Biochem Cell Biol; 2014 Aug; 53():547-57. PubMed ID: 24786297
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Overview of Recent Advances in Epigenetics in Pediatric Acute Lymphoblastic Leukemia.
Drożak P; Bryliński Ł; Zawitkowska J
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358802
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic modifications and targeted therapy in pediatric acute myeloid leukemia.
Xu H; Wen Y; Jin R; Chen H
Front Pediatr; 2022; 10():975819. PubMed ID: 36147798
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug Resistance.
Saint Fleur-Lominy S; Evensen NA; Bhatla T; Sethia G; Narang S; Choi JH; Ma X; Yang JJ; Kelly S; Raetz E; Harvey RC; Willman C; Loh ML; Hunger SP; Brown PA; Getz KM; Meydan C; Mason CE; Tsirigos A; Carroll WL
Cancer Res; 2020 Dec; 80(23):5189-5202. PubMed ID: 33067268
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics.
Fathi E; Farahzadi R; Montazersaheb S; Bagheri Y
Curr Gene Ther; 2021; 21(1):60-71. PubMed ID: 33183201
[TBL] [Abstract][Full Text] [Related]
11. The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemia.
Meyer LK; Hermiston ML
Cancer Drug Resist; 2019; 2(4):1164-1177. PubMed ID: 35582273
[TBL] [Abstract][Full Text] [Related]
12. Novel biological insights in T-cell acute lymphoblastic leukemia.
Durinck K; Goossens S; Peirs S; Wallaert A; Van Loocke W; Matthijssens F; Pieters T; Milani G; Lammens T; Rondou P; Van Roy N; De Moerloose B; Benoit Y; Haigh J; Speleman F; Poppe B; Van Vlierberghe P
Exp Hematol; 2015 Aug; 43(8):625-39. PubMed ID: 26123366
[TBL] [Abstract][Full Text] [Related]
13. Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
Boila LD; Sengupta A
Exp Hematol; 2020 Dec; 92():19-31. PubMed ID: 32950598
[TBL] [Abstract][Full Text] [Related]
14. Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.
Lejman M; Chałupnik A; Chilimoniuk Z; Dobosz M
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269896
[TBL] [Abstract][Full Text] [Related]
15. Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia.
Figueroa ME; Chen SC; Andersson AK; Phillips LA; Li Y; Sotzen J; Kundu M; Downing JR; Melnick A; Mullighan CG
J Clin Invest; 2013 Jul; 123(7):3099-111. PubMed ID: 23921123
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia.
Bhatla T; Wang J; Morrison DJ; Raetz EA; Burke MJ; Brown P; Carroll WL
Blood; 2012 May; 119(22):5201-10. PubMed ID: 22496163
[TBL] [Abstract][Full Text] [Related]
17. The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia.
Janczar S; Janczar K; Pastorczak A; Harb H; Paige AJ; Zalewska-Szewczyk B; Danilewicz M; Mlynarski W
Cancers (Basel); 2017 Jan; 9(1):. PubMed ID: 28054944
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics in pediatric acute lymphoblastic leukemia.
Nordlund J; Syvänen AC
Semin Cancer Biol; 2018 Aug; 51():129-138. PubMed ID: 28887175
[TBL] [Abstract][Full Text] [Related]
19. Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia.
Tardif M; Souza A; Krajinovic M; Bittencourt H; Tran TH
Expert Opin Pharmacother; 2021 Oct; 22(14):1871-1887. PubMed ID: 34011251
[No Abstract] [Full Text] [Related]
20. DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML).
Krali O; Palle J; Bäcklin CL; Abrahamsson J; Norén-Nyström U; Hasle H; Jahnukainen K; Jónsson ÓG; Hovland R; Lausen B; Larsson R; Palmqvist L; Staffas A; Zeller B; Nordlund J
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
